Volume 125, Issue 5, Pages (November 2003)

Slides:



Advertisements
Similar presentations
Inflammatory Bowel Disease-Associated Interleukin-33 Is Preferentially Expressed in Ulceration-Associated Myofibroblasts  Jon Sponheim, Jürgen Pollheimer,
Advertisements

IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 124, Issue 7, Pages (June 2003)
Volume 130, Issue 2, Pages (February 2006)
Volume 132, Issue 1, Pages (January 2007)
Substance P Mediates Proinflammatory Cytokine Release From Mesenteric Adipocytes in Inflammatory Bowel Disease Patients  Aristea Sideri, Kyriaki Bakirtzi,
Volume 132, Issue 3, Pages (March 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 126, Issue 3, Pages (March 2004)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 133, Issue 6, Pages (December 2007)
Volume 144, Issue 5, Pages e10 (May 2013)
Volume 125, Issue 5, Pages (November 2003)
Volume 25, Issue 2, Pages (August 2006)
Volume 129, Issue 3, Pages (September 2005)
Volume 132, Issue 1, Pages (January 2007)
Volume 133, Issue 5, Pages (November 2007)
IL-2–mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP  Caigan Du, Qiunong Guan, Ziqin Yin, Robert.
Volume 132, Issue 4, Pages (April 2007)
Volume 136, Issue 2, Pages (February 2009)
Volume 133, Issue 6, Pages (December 2007)
Volume 132, Issue 1, Pages (January 2007)
Volume 16, Issue 12, Pages (September 2016)
Expression and Function of RIG-I in Oral Keratinocytes and Fibroblasts
Volume 132, Issue 1, Pages (January 2007)
Volume 129, Issue 3, Pages (September 2005)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 140, Issue 4, Pages e1 (April 2011)
IL-31 Receptor Alpha Expression in Epidermal Keratinocytes Is Modulated by Cell Differentiation and Interferon Gamma  Ruth Heise, Mark M. Neis, Yvonne.
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Freimut Schliess, Anna Kordelia Kurz, Dieter Häussinger 
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Volume 147, Issue 1, Pages (July 2014)
Volume 141, Issue 1, Pages e1 (July 2011)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Volume 129, Issue 2, Pages (August 2005)
Volume 118, Issue 6, Pages (June 2000)
Volume 16, Issue 12, Pages (September 2016)
Volume 125, Issue 6, Pages (December 2003)
Volume 119, Issue 2, Pages (August 2000)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 129, Issue 5, Pages (November 2005)
Volume 132, Issue 5, Pages (May 2007)
GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N- Cadherin Expression and Decreasing FAK Phosphorylation  Jobin K. John, Kim.
Volume 135, Issue 2, Pages e2 (August 2008)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Suppressor of Cytokine Signaling 1/JAB and Suppressor of Cytokine Signaling 3/Cytokine-Inducible SH2 Containing Protein 3 Negatively Regulate the Signal.
Volume 124, Issue 7, Pages (June 2003)
Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A
Leptin: A pivotal mediator of intestinal inflammation in mice
Maria Rescigno, Iliyan D. Iliev  Gastroenterology 
Volume 59, Issue 2, Pages (February 2001)
TNF-α Suppresses α-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing  Mytien T. Goldberg, Yuan-Ping.
4-Tertiary Butyl Phenol Exposure Sensitizes Human Melanocytes to Dendritic Cell- Mediated Killing: Relevance to Vitiligo  Tara M. Kroll, Hemamalini Bommiasamy,
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Deficient SOCS3 and SHP-1 Expression in Psoriatic T Cells
Volume 130, Issue 2, Pages (February 2006)
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Volume 128, Issue 3, Pages (March 2005)
Volume 126, Issue 1, Pages (January 2004)
T. Shibahara, J.N. Wilcox, T. Couse, J.L. Madara  Gastroenterology 
Volume 122, Issue 7, Pages (June 2002)
Keratinocytes Inhibit Expression of Connective Tissue Growth Factor in Fibroblasts In Vitro by an Interleukin-1α-Dependent Mechanism  Daniel Nowinski,
Volume 136, Issue 7, Pages (June 2009)
Volume 126, Issue 3, Pages (March 2004)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Volume 126, Issue 5, Pages (May 2004)
The Activity of Caspase-1 Is Increased in Lesional Psoriatic Epidermis
Presentation transcript:

Volume 125, Issue 5, Pages 1341-1354 (November 2003) Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase1   Sandra Nicole Leeb, Daniela Vogl, Manuela Gunckel, Stephan Kiessling, Werner Falk, Michael Göke, Jürgen Schölmerich, Cornelia Maria Gelbmann, Gerhard Rogler  Gastroenterology  Volume 125, Issue 5, Pages 1341-1354 (November 2003) DOI: 10.1016/j.gastro.2003.07.004

Figure 1 Immunocytochemical characterization of CLPF. The first column shows stainings of control-CLPF, the second column shows stainings of CD-CLPF, and the third column shows stainings of UC-CLPF. All cultures showed a positive and homogeneous red staining with anti-fibroblast antibody ASO2 (row A), vimentin (row B), and vinculin (row C). Smooth muscle actin (row D), myosin (row E), and desmin (F) were also found in the investigated CLPF cultures but not ubiquitously. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 2 Reduced migration of CD- and UC-CLPF. The migration was induced with 24 hours (A) or 48 hours (B) conditioned media of control-, CD-, or UC-CLPF. CD-CLPF (shaded bars) and UC-CLPF (solid bars) showed a reduced migratory response toward conditioned media when compared with control-CLPF (open bars). Statistics: (A) ∗∗Mann-Whitney rank sum test, P < 0.0001; ∗t test, P = 0.0005; #t test, P = 0.006; §t test, P = 0.002. (B) ∗∗Mann-Whitney rank sum test, P < 0.0001; ∗t test, P = 0.0004; #Mann-Whitney rank sum test, P = 0.05; §Mann-Whitney rank sum test, P = 0.02. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 3 Inhibition of the migration of control-CLPF by IFN-γ and TNF. Twenty-four-hour-conditioned medium of CLPF with additional IFN-γ (A) or TNF (B) in the indicated concentrations was used for migration assays with CLPF in the modified Boyden chamber. Migration induced with conditioned medium without IFN-γ or TNF addition was used as control. The migration is given as the percentage of the control: (A) 100% = 62 CLPF/hpf; (B) 100% = 50 CLPF/hpf. Statistics: (A) 20 ng/mL IFN-γ Mann-Whitney rank sum test, P = 0.0341; 30 ng/mL IFN-γ t test, P = 0.0018; 40 ng/mL IFN-γ t test, P = 0.0006; 50 ng/mL IFN-γ Mann-Whitney rank sum test, P < 0.0001. (B): 10 ng/mL TNF t test, P = 0.0455; 20 ng/mL TNF t test, P = 0.0137; 30 ng/mL TNF t test, P = 0.0088. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 4 Reduced migration of control-CLPF after preincubation with IFN-γ and TNF. CLPF were incubated for 3 days with IFN-γ (10 ng/mL) or TNF (20 ng/mL) or with both cytokines simultaneously (A and B). Furthermore, CLPF were incubated for 3 days with IFN-γ (10 ng/mL) or TNF (20 ng/mL) or with both cytokines simultaneously and cultured for another 7 days without any cytokine (C and D). Subsequently, it was investigated whether 24 hours (solid bars) and 48 hours (open bars) conditioned media of control-CLPF (A and C) or 24 hours (solid bars) and 48 hours (open bars) conditioned media of CD-CLPF (B and D) induce migration in these cells. Statistics: (A) ∗Wilcoxon signed rank test, P = 0.0005; ∗∗paired t test, P < 0.0001. (B): #Mann-Whitney rank sum test, P = 0.06; §Wilcoxon signed rank test, P = 0.009; ∗∗paired t test, P < 0.0001; ∗paired t test, P < 0.0006. (C): #Wilcoxon signed rank test, P = 0.05; ∗Wilcoxon signed rank test, P = 0.004; §paired t test, P = 0.013; ∗∗paired t test, P < 0.0001. (D) #paired t test, P = 0.002; §paired t test, P = 0.001; ∗paired t test, P = 0.003; ##paired t test, P = 0.0003; ∗∗paired t test, P = 0.0002. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 5 Cell viability analyses. XTT-based colorimetric analyses for quantification of cell viability of control-CLPF incubated for 3 days with IFN-γ (10 ng/mL) or TNF (20 ng/mL) or with both cytokines simultaneously and of CD-CLPF and UC-CLPF cultured in parallel (A) and of cytokine-treated control-CLPF cultured for another 7 days without any cytokine and of CD-CLPF and UC-CLPF cultured in parallel (B). IFN-γ/TNF-incubated control-CLPF, CD-, and UC-CLPF showed no decreased cell viability. CLPF of 3 different control, CD and UC patients were used in the experiments. Statistics: (A): #Paired t test, P = 0.055; ∗Wilcoxon signed rank test, P = 0.02. (B) ∗Paired t test, P = 0.03. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 6 Cell-cycle analyses. The percentage of control-CLPF and cytokine-incubated control-CLPF, CD-, and UC-CLPF in the S-phase was determined by FACS. (A) Percentage of cells in the S-phase of control-CLPF incubated for 3 days with IFN-γ (10 ng/mL) or TNF (20 ng/mL) or with both cytokines simultaneously and of CD-CLPF and UC-CLPF cultured in parallel. (B) Shows percentage of cells in the S-phase of cytokine-treated control-CLPF cultured for another 7 days without any cytokine and of CD-CLPF and UC-CLPF cultured in parallel. CLPF of 4 different control and 3 different CD and UC patients were used in the experiments. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 7 Decrease of FAK protein and FAK phosphorylation in migrating CD- and UC-CLPF. Cells were lysed 4 hours and 8 hours after the induction of migration by wounding a confluent CLPF monolayer. Resting cells (0 hours) were lysed and used as control. FAK protein and its autophosphorylation were determined by Western blotting. (A) Shows exemplary blots for CLPF of one control, Crohn’s disease, or ulcerative colitis patient. The quantitative analyses of all blots were standardized to β-actin and are given as the percentage of the 0 hours time point. (B) Shows total FAK protein and (C) FAK autophosphorylation at tyrosine 397. CLPF of 3 different control and CD patients and 2 different UC patients were used in the experiments. Data were not statistically significant. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 8 Regulation of FAK protein and FAK phosphorylation in migrating cytokine-treated control-CLPF. Control-CLPF were preincubated for 3 days with IFN-γ (10 ng/mL) or TNF (20 ng/mL) or with both cytokines simultaneously. Cells were lysed 4 hours and 8 hours after the induction of migration by wounding a confluent CLPF monolayer. Resting cells (0 hours) were lysed and used as control. Pretreatment with IFN-γ and TNF induced a reduction of FAK protein and phosphorylation in control-CLPF. One exemplary Western blot for each assay group is shown in A. The quantitative analyses of all blots were standardized to β-actin and are given as the percentage of the 0 hours time point. (B) Shows total FAK protein and (C) FAK autophosphorylation at tyrosin 397. CLPF of 3 different control, CD, and UC patients were used in the experiments. Statistics: (C) ∗Zero hours time point of TNF-treated CLPF vs. 8 hours time point of TNF-treated CLPF, Student t test, P = 0.0021. Not indicated in the Figure: zero hours time point of untreated CLPF vs. 0 hours time point of TNF-treated CLPF; Student t test, P = 0.0372. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 9 Regulation of FAK protein and FAK phosphorylation in migrating control-CLPF exposed for 3 days to IFN-γ and TNF and subsequent culture for another 7 days under normal conditions without IFN-γ and TNF supplementation. Cells were lysed 4 hours and 8 hours after the induction of migration by wounding a confluent CLPF monolayer. Resting cells (0 hours) were lysed and used as control. Pretreatment with both IFN-γ and TNF induced a reduction of FAK protein and phosphorylation in control-CLPF. One exemplary Western blot for each assay group is shown in A, and, again, the quantitative analyses of all blots were standardized to β-actin and are given as the percentage of the 0 hours time point. (B) Shows total FAK protein and (C) FAK autophosphorylation at tyrosine 397. CLPF of 3 different control, CD, and UC patients were used in the experiments. Data were not statistically significant. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)

Figure 10 FAK mRNA expression was determined by Northern blotting. The migration of CLPF was induced by wounding a confluent CLPF monolayer, and mRNA was isolated 4 hours and 8 hours after the induction of migration. Resting cells (0 hours) were lysed and used as control. No differences in FAK mRNA expression could be observed. CLPF mRNA (lanes 10 and 11) was investigated because the FAK bands were of similar size as the 28S bands. Therefore, mRNA was assayed together with the RNA probes to exclude a confusion of the FAK bands with the 28S bands. Gastroenterology 2003 125, 1341-1354DOI: (10.1016/j.gastro.2003.07.004)